Depression and Anxiety Symptoms in Headache Disorders: An Observational, Cross-Sectional Study.

IF 3.2 Q2 CLINICAL NEUROLOGY Neurology International Pub Date : 2024-03-18 DOI:10.3390/neurolint16020026
Leonidas Mantonakis, Ioanna Belesioti, Christina I Deligianni, Vasilis Natsis, Euthimia Mitropoulou, Elina Kasioti, Maria Lypiridou, Dimos D Mitsikostas
{"title":"Depression and Anxiety Symptoms in Headache Disorders: An Observational, Cross-Sectional Study.","authors":"Leonidas Mantonakis, Ioanna Belesioti, Christina I Deligianni, Vasilis Natsis, Euthimia Mitropoulou, Elina Kasioti, Maria Lypiridou, Dimos D Mitsikostas","doi":"10.3390/neurolint16020026","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Headache disorders have been associated with anxiety and depressive disorders. The aim of this study was to assess symptoms of anxiety and depression in a large sample of individuals with different headache disorders (HDs) in order to determine whether their frequency differs by headache type.</p><p><strong>Methods: </strong>Consecutive individuals with headache attending a headache outpatient clinic were interviewed with the HAM-D and HAM-A, along with age, sex, and education matched non-headache individuals.</p><p><strong>Results: </strong>Individuals numbering 2673 with headache (females 71.2%) and 464 non-headache individuals (females 70.9%) were interviewed (with participation rates of 98.3% and 91.0%, respectively). Migraine was diagnosed in 49.7%, tension-type headache in 38%, cluster headache 5.2%, and medication overuse (MO) in 21.8%. Participants with HD scored more in HAM-A (OR = 4.741, CI95%: 3.855-5.831, <i>p</i> < 0.001) and HAM-D scales (OR = 2.319, CI95%: 1.892-2.842, <i>p</i> < 0.001) than non-headache individuals. Participants with chronic HDs (≥15 days with headache for ≥3 consecutive months; 52.5%) scored higher for both HAM-A (OR = 1.944, CI95%: 1.640-2.303, <i>p</i> < 0.001) and HAM-D (OR = 1.625, CI95%: 1.359-1.944, <i>p</i> < 0.001) than those with episodic HDs (33.1%), as did participants with MO vs. participants without MO (OR = 3.418, CI95%: 2.655-4.399, <i>p</i> < 0.001 for HAM-A, OR = 3.043, CI95%: 2.322-3.986, <i>p</i> < 0.001 for HAM-D). Female and low-educated participants scored higher on both scales.</p><p><strong>Conclusion: </strong>Because symptoms of anxiety and depression are substantial in people with HD, the treating physicians should look out for such symptoms and manage them appropriately.</p>","PeriodicalId":19130,"journal":{"name":"Neurology International","volume":"16 2","pages":"356-369"},"PeriodicalIF":3.2000,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961742/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/neurolint16020026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Headache disorders have been associated with anxiety and depressive disorders. The aim of this study was to assess symptoms of anxiety and depression in a large sample of individuals with different headache disorders (HDs) in order to determine whether their frequency differs by headache type.

Methods: Consecutive individuals with headache attending a headache outpatient clinic were interviewed with the HAM-D and HAM-A, along with age, sex, and education matched non-headache individuals.

Results: Individuals numbering 2673 with headache (females 71.2%) and 464 non-headache individuals (females 70.9%) were interviewed (with participation rates of 98.3% and 91.0%, respectively). Migraine was diagnosed in 49.7%, tension-type headache in 38%, cluster headache 5.2%, and medication overuse (MO) in 21.8%. Participants with HD scored more in HAM-A (OR = 4.741, CI95%: 3.855-5.831, p < 0.001) and HAM-D scales (OR = 2.319, CI95%: 1.892-2.842, p < 0.001) than non-headache individuals. Participants with chronic HDs (≥15 days with headache for ≥3 consecutive months; 52.5%) scored higher for both HAM-A (OR = 1.944, CI95%: 1.640-2.303, p < 0.001) and HAM-D (OR = 1.625, CI95%: 1.359-1.944, p < 0.001) than those with episodic HDs (33.1%), as did participants with MO vs. participants without MO (OR = 3.418, CI95%: 2.655-4.399, p < 0.001 for HAM-A, OR = 3.043, CI95%: 2.322-3.986, p < 0.001 for HAM-D). Female and low-educated participants scored higher on both scales.

Conclusion: Because symptoms of anxiety and depression are substantial in people with HD, the treating physicians should look out for such symptoms and manage them appropriately.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
头痛症患者的抑郁和焦虑症状:一项观察性横断面研究。
背景:头痛症与焦虑症和抑郁症有关。本研究旨在对不同头痛症(HD)患者的焦虑和抑郁症状进行大样本评估,以确定焦虑和抑郁症状的出现频率是否因头痛类型而异:方法:对在头痛门诊就诊的连续头痛患者以及年龄、性别和教育程度相匹配的非头痛患者进行 HAM-D 和 HAM-A 问卷调查:共有 2673 名头痛患者(女性占 71.2%)和 464 名非头痛患者(女性占 70.9%)接受了访谈(参与率分别为 98.3% 和 91.0%)。49.7%的人被诊断为偏头痛,38%的人被诊断为紧张型头痛,5.2%的人被诊断为丛集性头痛,21.8%的人被诊断为药物过度使用(MO)。与非头痛患者相比,HD 患者的 HAM-A 评分(OR = 4.741,CI95%:3.855-5.831,p < 0.001)和 HAM-D 评分(OR = 2.319,CI95%:1.892-2.842,p < 0.001)更高。慢性头痛患者(头痛天数≥15 天,连续≥3 个月;52.5%)的 HAM-A 评分(OR = 1.944,CI95%:1.640-2.303,p <0.001)和 HAM-D 评分(OR = 1.625,CI95%:1.359-1.944,p <0.001)均高于偶发性头痛患者(33.1%),患有 MO 的患者与未患有 MO 的患者相比也是如此(OR = 3.418,CI95%:2.655-4.399,p <0.001):就 HAM-A 而言,OR = 3.043,CI95%:2.322-3.986,P < 0.001:HAM-D的OR = 3.043,CI95%:2.322-3.986,p < 0.001)。女性和低学历参与者在两个量表上的得分都较高:由于焦虑和抑郁症状在 HD 患者中很常见,因此治疗医生应注意这些症状并加以适当处理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neurology International
Neurology International CLINICAL NEUROLOGY-
CiteScore
3.70
自引率
3.30%
发文量
69
审稿时长
11 weeks
期刊最新文献
Sensitization and Habituation of Hyper-Excitation to Constant Presentation of Pattern-Glare Stimuli. Evolution of Cognitive Disorders in Patients with Mild Cognitive Impairment (MCI) After Ischemic Stroke: Secondary Data Analysis from the Improved Health Care in Neurology and Psychiatry-Longer Life (IHCNP) Study. Macamides as Potential Therapeutic Agents in Neurological Disorders. Slow Subcutaneous Release of Glatiramer Acetate or CD40-Targeting Peptide KGYY6 Is More Advantageous in Treating Ongoing Experimental Autoimmune Encephalomyelitis. Mindfulness-Based Interventions and the Hypothalamic-Pituitary-Adrenal Axis: A Systematic Review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1